Trial NCT02972294

View at ClinicalTrials.gov 
Org. Study IDs: 49RC16_0014

Last trial update was posted on 2022-08-02

MeSH Interventions

Ferric Compounds Iron Iron isomaltoside 1000 Tranexamic Acid

MeSH Conditions

Fractures, Bone Hip Fractures

Other Conditions

Anemia Hip Fractures Pathologic

Stopping Reasons

1year inclusion hold due to PV new fact (Monofer hold for risk revaluation) DSMB Interim analysis : 1treatment with important transfusion risk reduction/inclusions issues (COVID)/sites change of practice if study continue=>stop inclusions

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID